Literature DB >> 11839585

Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.

Nicholas A Shackel1, Peter H McGuinness, Catherine A Abbott, Mark D Gorrell, Geoffrey W McCaughan.   

Abstract

The pathogenesis of hepatitis C virus (HCV)-associated liver injury involves many genes from multiple pathogenic pathways. cDNA array analysis, which examines the expression of many genes simultaneously, was used to achieve new insights into HCV liver injury. Membrane-based cDNA arrays of 874 genes compared HCV-associated cirrhosis with autoimmune hepatitis-associated cirrhosis as an inflammatory and cirrhotic control, and with nondiseased liver tissue. Array analysis identified many differentially expressed genes that are important in inflammation, fibrosis, proliferation, signaling, apoptosis, and oxidative stress. Genes up-regulated in HCV-associated cirrhosis were predominantly associated with a Th1 immune response, fibrosis, cellular proliferation, and apoptosis. Novel observations of differential gene expression included increased expression of secreted apoptosis-related protein 3, a Wnt pathway gene possibly involved in cellular apoptosis. EMMPRIN (CD147) and discoidin domain receptor 1 (CD167) were also shown to be increased and are likely to play a role in liver fibrosis. Real-time quantitative reverse transcriptase-polymerase chain reaction confirmed the increased expression of 15 genes. The comparison of HCV cirrhosis with autoimmune hepatitis cirrhosis showed a marked difference in the apoptosis-associated gene profile with HCV cirrhosis characterized by increased proapoptotic gene expression whereas autoimmune hepatitis was characterized by increased expression of both antiapoptotic and proapoptotic genes. Furthermore, expression of beta-catenin and the fibrosis-associated protein EMMPRIN were localized by immunohistochemistry to the plasma membranes of hepatocytes and biliary epithelium. In conclusion, HCV-associated cirrhosis was characterized by a proinflammatory, profibrotic, and proapoptotic gene expression profile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839585      PMCID: PMC1850631          DOI: 10.1016/S0002-9440(10)64884-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  62 in total

1.  A DNA chip off the aging block.

Authors:  V J Cristofalo
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

2.  Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I.

Authors:  J L Yin; N A Shackel; A Zekry; P H McGuinness; C Richards; K V Putten; G W McCaughan; J M Eris; G A Bishop
Journal:  Immunol Cell Biol       Date:  2001-06       Impact factor: 5.126

3.  Differential gene expression between chronic hepatitis B and C hepatic lesion.

Authors:  M Honda; S Kaneko; H Kawai; Y Shirota; K Kobayashi
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

4.  Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

Authors:  J T Gerlach; H M Diepolder; M C Jung; N H Gruener; W W Schraut; R Zachoval; R Hoffmann; C A Schirren; T Santantonio; G R Pape
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

5.  Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression.

Authors:  N A Shackel; P H McGuinness; C A Abbott; M D Gorrell; G W McCaughan
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

6.  Molecular dissection of the mitogenic effect of hepatocytes on cultured hepatic stellate cells.

Authors:  A M Gressner; B Lahme; A Brenzel
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

7.  c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.

Authors:  J D Collier; K Guo; J Mathew; F E May; M K Bennett; I P Corbett; M F Bassendine; A D Burt
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

8.  Histological patterns of prolonged hepatitis C infection.

Authors:  J M Roberts; J W Searle; W G Cooksley
Journal:  Gastroenterol Jpn       Date:  1993-05

Review 9.  Cellular and molecular mechanisms of hepatocarcinogenesis.

Authors:  C E Rogler; F V Chisari
Journal:  Semin Liver Dis       Date:  1992-08       Impact factor: 6.115

10.  The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily.

Authors:  C Biswas; Y Zhang; R DeCastro; H Guo; T Nakamura; H Kataoka; K Nabeshima
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

View more
  44 in total

1.  Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.

Authors:  Amitava Das; Uday Shergill; Lokendra Thakur; Sutapa Sinha; Raul Urrutia; Debabrata Mukhopadhyay; Vijay H Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-25       Impact factor: 4.052

Review 2.  Genetics of hepatocellular carcinoma.

Authors:  Andreas Teufel; Frank Staib; Stephan Kanzler; Arndt Weinmann; Henning Schulze-Bergkamen; Peter-R Galle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

Review 3.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 4.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

5.  Gene profiling of early and advanced liver disease in chronic hepatitis C patients.

Authors:  Saira Sarfraz Khalid; Saeed Hamid; Anwar A Siddiqui; Asaf Qureshi; Nilofer Qureshi
Journal:  Hepatol Int       Date:  2011-01-22       Impact factor: 6.047

Review 6.  Pathogenic interactions between alcohol and hepatitis C.

Authors:  Gyongyi Szabo
Journal:  Curr Gastroenterol Rep       Date:  2003-02

7.  Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs.

Authors:  Mark A Pershouse; Aubrey M Smartt; Corbin Schwanke; Elizabeth A Putnam
Journal:  Genomics       Date:  2009-05-13       Impact factor: 5.736

Review 8.  Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.

Authors:  V Yurchenko; S Constant; E Eisenmesser; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

9.  Differentially regulated gene expression associated with hepatitis C virus clearance.

Authors:  Carolyn Z Grimes; Lu-Yu Hwang; Peng Wei; Dimpy P Shah; Kelly A Volcik; Eric L Brown
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

10.  The Stimulation of CD147 Induces MMP-9 Expression through ERK and NF-kappaB in Macrophages: Implication for Atherosclerosis.

Authors:  Ju-Young Kim; Won-Jung Kim; Ho Kim; Kyoungho Suk; Won-Ha Lee
Journal:  Immune Netw       Date:  2009-06-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.